Angiotensin‐Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Are Associated With Improved Outcome but Do Not Prevent New‐Onset Atrial Fibrillation After Acute Myocardial Infarction

BACKGROUND: Treatment with renin‐angiotensin system (RAS) inhibitors might restrain the structural/electrical remodeling associated with atrial fibrillation (AF). Limited evidence exists regarding the potential benefits of RAS inhibition post‐acute myocardial infarction (AMI) in patients with AF. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Batra, Gorav, Lindhagen, Lars, Andell, Pontus, Erlinge, David, James, Stefan, Spaak, Jonas, Oldgren, Jonas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524029/
https://www.ncbi.nlm.nih.gov/pubmed/28320744
http://dx.doi.org/10.1161/JAHA.116.005165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524029/
https://www.ncbi.nlm.nih.gov/pubmed/28320744
http://dx.doi.org/10.1161/JAHA.116.005165

Ejemplares similares